Literature DB >> 11927836

Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit.

Dieter Rosskopf1, Iris Manthey, Winfried Siffert.   

Abstract

The 825T-allele of the gene GNB3 encoding the G protein beta3 subunit is associated with hypertension and obesity, and identifies individuals highly responsive to diuretic therapy. Gbeta3s, a Gbeta3 protein variant generated by alternative splicing in carriers of the 825T-allele, is linked to increased signal transduction and is a potential cause for the observed pathophysiology. Here, we searched the entire GNB3 gene for additional polymorphisms and analysed their prevalence in Caucasian, black African and Asian populations. We detected six novel single nucleotide polymorphisms which were termed according to their location as G76A, G1906T, G2906A, A3882C, G5177A, and G5249A. Furthermore, we found a CACA-insertion-deletion polymorphism at position 6496. Genotyping and association studies resulted in the definition of two major GNB3 haplotypes, termed 'C-haplotype' (alleles 825C, 3882A, 5249G, 6496CACA-) and 'T-haplotype' (alleles 825T, 3882C, 5249A, 6496CACA+). Molecular modelling studies revealed that the pre-mRNA structures of both haplotypes exhibit marked differences which may account for the alternative splicing predominantly observed with the T-haplotype. The prevalence of these haplotypes in major ethnic populations differs considerably. Furthermore, we detected additional frequent GNB3 polymorphisms. These variants were restricted to one or two major ethnic populations. Our results will aid future studies on population-specific effects of the GNB3 variants on risk and course of frequent diseases, including hypertension, obesity, stroke and myocardial infarction. Furthermore, they will contribute to the understanding of GNB3-related population-specific pharmacogenetic differences in the response to major drugs, as already shown for diuretics and antidepressants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927836     DOI: 10.1097/00008571-200204000-00005

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  21 in total

Review 1.  New advances in identifying genetic anomalies in stroke-prone probands.

Authors:  James F Meschia; Bradford B Worrall
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

2.  New advances in identifying genetic anomalies in stroke-prone probands.

Authors:  James F Meschia; Bradford B Worrall
Journal:  Curr Neurol Neurosci Rep       Date:  2004-09       Impact factor: 5.081

3.  Distribution of the GNB3 825C>T polymorphism among Brazilians: impact of population structure.

Authors:  Daniela D Vargens; Lucas Almendra; Cláudio J Struchiner; Guilherme Suarez-Kurtz
Journal:  Eur J Clin Pharmacol       Date:  2007-12-06       Impact factor: 2.953

4.  The structure of common genetic variation in United States populations.

Authors:  Stephen L Guthery; Benjamin A Salisbury; Manish S Pungliya; J Claiborne Stephens; Michael Bamshad
Journal:  Am J Hum Genet       Date:  2007-10-16       Impact factor: 11.025

5.  GNB3 C825T Polymorphism and Myocardial Recovery in Peripartum Cardiomyopathy: Results of the Multicenter Investigations of Pregnancy-Associated Cardiomyopathy Study.

Authors:  Richard Sheppard; Eileen Hsich; Julie Damp; Uri Elkayam; Angela Kealey; Gautam Ramani; Mark Zucker; Jeffrey D Alexis; Benjamin D Horne; Karen Hanley-Yanez; Jessica Pisarcik; Indrani Halder; James D Fett; Dennis M McNamara
Journal:  Circ Heart Fail       Date:  2016-03       Impact factor: 8.790

6.  β-blocker therapy and heart rate control during exercise testing in the general population: role of a common G-protein β-3 subunit variant.

Authors:  Marcus Dörr; Carsten O Schmidt; Thomas Spielhagen; Alexa Bornhorst; Katharina Hentschel; Christina Franz; Klaus Empen; Thomas Kocher; Scott R Diehl; Heyo K Kroemer; Henry Völzke; Ralf Ewert; Stephan B Felix; Dieter Rosskopf
Journal:  Pharmacogenomics       Date:  2010-09       Impact factor: 2.533

7.  Identification and characterization of G beta 3s2, a novel splice variant of the G-protein beta 3 subunit.

Authors:  Dieter Rosskopf; Iris Manthey; Christiane Habich; Marzena Kielbik; Andreas Eisenhardt; Christiane Nikula; Melanie Urban; Stefanie Kohnen; Eva Graf; Ursula Ravens; Winfried Siffert
Journal:  Biochem J       Date:  2003-04-01       Impact factor: 3.857

8.  A longitudinal study of the association between the GNB3 C825T polymorphism and metabolic disturbance in bipolar II patients treated with valproate.

Authors:  P S Chen; H H Chang; C-C Huang; C C Lee; S-Y Lee; S-L Chen; S-Y Huang; Y K Yang; R-B Lu
Journal:  Pharmacogenomics J       Date:  2016-02-09       Impact factor: 3.550

Review 9.  G-protein beta3 subunit 825T allele and hypertension.

Authors:  Winfried Siffert
Journal:  Curr Hypertens Rep       Date:  2003-02       Impact factor: 5.369

10.  Further evidence supporting a role for gs signal transduction in severe malaria pathogenesis.

Authors:  Sarah Auburn; Andrew E Fry; Taane G Clark; Susana Campino; Mahamadou Diakite; Angela Green; Anna Richardson; Muminatou Jallow; Fatou Sisay-Joof; Margaret Pinder; Malcolm E Molyneux; Terrie E Taylor; Kasturi Haldar; Kirk A Rockett; Dominic P Kwiatkowski
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.